Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Fillit

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Journal of the American Geriatrics Society|March 31, 2018
Analysis of Episodes of Care in Medicare Beneficiaries Newly Diagnosed with Alzheimer's DiseaseRezaul K Khandker, Christopher M Black, Lin Xie, et al.
Journal of the American Medical Directors Association|October 30, 2010
Memantine discontinuation and the health status of nursing home residents with Alzheimer's diseaseHoward Fillit, Robert K Hofbauer, Juliana Setyawan, et al.
Alzheimer Disease and Associated Disorders|August 30, 2008
Older Americans' risk-benefit preferences for modifying the course of Alzheimer diseaseA Brett Hauber, F Reed Johnson, Howard Fillit, et al.
Journal of Alzheimer'S Disease : JAD|November 6, 2017
Economic Burden, Mortality, and Institutionalization in Patients Newly Diagnosed with Alzheimer's DiseaseChristopher M Black, Howard Fillit, Lin Xie, et al.
Neurology and Therapy|May 17, 2017
A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer's Disease PatientsNawal Bent-Ennakhil, Florence Coste, Lin Xie, et al.
International Journal of Geriatric Psychiatry|July 21, 2021
Impact of agitation in long-term care residents with dementia in the United StatesHoward Fillit, Myrlene S Aigbogun, Patrick Gagnon-Sanschagrin, et al.
JAMA Network Open|April 29, 2020
Association of the US Food and Drug Administration Antipsychotic Drug Boxed Warning With Medication Use and Health Outcomes in Elderly Patients With DementiaAnnalisa Rubino, Myrlene Sanon, Michael L Ganz, et al.
Journal of Alzheimer'S Disease : JAD|September 14, 2020
Real-World Treatment Patterns and Characteristics Among Patients with Agitation and Dementia in the United States: Findings from a Large, Observational, Retrospective Chart ReviewMyrlene Sanon Aigbogun, Martin Cloutier, Marjolaine Gauthier-Loiselle, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 5, 2004
Masculine vitality: pros and cons of testosterone in treating the andropauseSanjay Asthana, Shalendar Bhasin, Robert N Butler, et al.
Annals of the New York Academy of Sciences|April 24, 2014
Alzheimer's disease research and development: a call for a new research roadmapHoward H Feldman, Magali Haas, Sam Gandy, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Journal of the American Geriatrics Society|March 31, 2018
Analysis of Episodes of Care in Medicare Beneficiaries Newly Diagnosed with Alzheimer's DiseaseRezaul K Khandker, Christopher M Black, Lin Xie, et al.
Journal of the American Medical Directors Association|October 30, 2010
Memantine discontinuation and the health status of nursing home residents with Alzheimer's diseaseHoward Fillit, Robert K Hofbauer, Juliana Setyawan, et al.
Alzheimer Disease and Associated Disorders|August 30, 2008
Older Americans' risk-benefit preferences for modifying the course of Alzheimer diseaseA Brett Hauber, F Reed Johnson, Howard Fillit, et al.
Journal of Alzheimer'S Disease : JAD|November 6, 2017
Economic Burden, Mortality, and Institutionalization in Patients Newly Diagnosed with Alzheimer's DiseaseChristopher M Black, Howard Fillit, Lin Xie, et al.
Neurology and Therapy|May 17, 2017
A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer's Disease PatientsNawal Bent-Ennakhil, Florence Coste, Lin Xie, et al.
International Journal of Geriatric Psychiatry|July 21, 2021
Impact of agitation in long-term care residents with dementia in the United StatesHoward Fillit, Myrlene S Aigbogun, Patrick Gagnon-Sanschagrin, et al.
JAMA Network Open|April 29, 2020
Association of the US Food and Drug Administration Antipsychotic Drug Boxed Warning With Medication Use and Health Outcomes in Elderly Patients With DementiaAnnalisa Rubino, Myrlene Sanon, Michael L Ganz, et al.
Journal of Alzheimer'S Disease : JAD|September 14, 2020
Real-World Treatment Patterns and Characteristics Among Patients with Agitation and Dementia in the United States: Findings from a Large, Observational, Retrospective Chart ReviewMyrlene Sanon Aigbogun, Martin Cloutier, Marjolaine Gauthier-Loiselle, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 5, 2004
Masculine vitality: pros and cons of testosterone in treating the andropauseSanjay Asthana, Shalendar Bhasin, Robert N Butler, et al.
Annals of the New York Academy of Sciences|April 24, 2014
Alzheimer's disease research and development: a call for a new research roadmapHoward H Feldman, Magali Haas, Sam Gandy, et al.
Pageof 8